Economics of enhanced surveillance
During our project we will closely monitor our enhanced system’s performance and compare it to the current situation, identifying which activities do (or do not) provide good value for money. This will form a strong ground to convince potential funders of the value of investing in a surveillance programme that can improve public health in a cost-effective manner.
The targeted impacts will be provision of a scientific evidence base, including cost-effectiveness data and improved understanding of agricultural and economic change in a densely population small-holder system with increased market orientation.
This work package therefore seeks to:
- Determine baseline costs of surveillance of zoonotic disease in the study area;
- Estimate how improved surveillance will modify zoonotic disease management and control through a detailed study of economic, social, demographic, genetic, and epidemiological drivers and the way that these combine to produce an overall burden of disease;
- Estimate costs of the standard sample and diagnostic procedures;
- Influence decision support for local and national government;
- Determine the cost-effectiveness analysis of the proposed new surveillance strategies